Antiviral Treatment
- All
- News
- Videos
-
Understanding The Difference Between HMPV And RSV Respiratory Infections
HMPV Infection Vs. RSV Infection: Understanding the differences between HMPV and RSV is crucial for timely diagnosis, prevention, and management.
-
Baby's Dark-Brown Eyes Turn Blue After Covid-19 Treatment In Thailand: Report
The dark brown eyes of a 6-month-old infant in Thailand temporarily turned indigo blue after receiving a common COVID-19 treatment.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
WHO Aims To Help Poorer Countries Access Vaccine With $10 Covid Pills
A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aim to secure antiviral drugs for patients with mild symptoms for as little as $10 per course.
-
Thailand In Talks With Merck For 200,000 Courses Of New Covid Pill
Thailand's government is in talks with U.S. drugmaker Merck & Co to purchase 200,000 courses of the company's experimental antiviral pill for COVID-19 treatment, a Thai official said on Monday.
-
US Announces $3.2 Billion Plan To Develop Covid Antiviral Treatments
US announced plans on Thursday to spend $3.2 billion to accelerate the development and discovery of antiviral treatments against Covid-19 and future threats.
-
Jharkhand Seeks Centre's Permission To Import Remdesivir From Bangladesh
The Jharkhand government has reached out to some pharma companies in Bangladesh for importing the antiviral drug Remedisivir, which is used in the treatment of serious Covid patients, Chief Minister Hemant Soren tweeted on Sunday.
-
How To Check Remdesivir Availability Anywhere In India
Remdesivir, an injectable drug used for COVID-19 treatment, has been flying off the shelves in many states alongside the rocketing coronavirus cases and amid reports of shortage of the antiviral drug.
-
Remdesivir Not Life-Saving Covid Drug: Maharashtra Task Force
Expressing concern over the panic created by the shortage of Remdesivir, an antiviral drug, Maharashtra's COVID-19 task force has said that it was not a life-saving medicine in coronavirus treatment, and strongly advised against its "rampant and irra
-
Top Intensive Care Body Against Remdesivir Use For Sickest Covid Patients
Antiviral remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of one of the world's top bodies representing intensive care doctors said, in a blow to the drug developed by U.S. firm Gilead.
-
Understanding The Difference Between HMPV And RSV Respiratory Infections
HMPV Infection Vs. RSV Infection: Understanding the differences between HMPV and RSV is crucial for timely diagnosis, prevention, and management.
-
Baby's Dark-Brown Eyes Turn Blue After Covid-19 Treatment In Thailand: Report
The dark brown eyes of a 6-month-old infant in Thailand temporarily turned indigo blue after receiving a common COVID-19 treatment.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
WHO Aims To Help Poorer Countries Access Vaccine With $10 Covid Pills
A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aim to secure antiviral drugs for patients with mild symptoms for as little as $10 per course.
-
Thailand In Talks With Merck For 200,000 Courses Of New Covid Pill
Thailand's government is in talks with U.S. drugmaker Merck & Co to purchase 200,000 courses of the company's experimental antiviral pill for COVID-19 treatment, a Thai official said on Monday.
-
US Announces $3.2 Billion Plan To Develop Covid Antiviral Treatments
US announced plans on Thursday to spend $3.2 billion to accelerate the development and discovery of antiviral treatments against Covid-19 and future threats.
-
Jharkhand Seeks Centre's Permission To Import Remdesivir From Bangladesh
The Jharkhand government has reached out to some pharma companies in Bangladesh for importing the antiviral drug Remedisivir, which is used in the treatment of serious Covid patients, Chief Minister Hemant Soren tweeted on Sunday.
-
How To Check Remdesivir Availability Anywhere In India
Remdesivir, an injectable drug used for COVID-19 treatment, has been flying off the shelves in many states alongside the rocketing coronavirus cases and amid reports of shortage of the antiviral drug.
-
Remdesivir Not Life-Saving Covid Drug: Maharashtra Task Force
Expressing concern over the panic created by the shortage of Remdesivir, an antiviral drug, Maharashtra's COVID-19 task force has said that it was not a life-saving medicine in coronavirus treatment, and strongly advised against its "rampant and irra
-
Top Intensive Care Body Against Remdesivir Use For Sickest Covid Patients
Antiviral remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of one of the world's top bodies representing intensive care doctors said, in a blow to the drug developed by U.S. firm Gilead.
